StockCIK 1534969

SERA PROGNOSTICS, INC. (SERA): Insider Trades and Fund Holdings

In the past 12 months, SERA PROGNOSTICS, INC. insiders reported 0 open-market purchases worth $0 and 6 sales worth $80K; 0 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$80KSold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 13, 2026.

Recent SERA insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 13	Oct 12	Tiffany Eul Davis InglisChief Medical Officer	Chief Medical Officer	▼ SELL	8,024	2.03	$16K	−8.8%	Form 4 ↗
Sep 11	Sep 10	Zhenya LindgardtCEO	CEO	▼ SELL	7,022	2.00	$14K	−0.8%	Form 4 ↗
Sep 11	Sep 10	Benjamin JacksonGeneral Counsel	General Counsel	▼ SELL	2,190	2.00	$4K	−1.4%	Form 4 ↗
Sep 11	Sep 10	Dyaarl Lee Anderson JrChief Commercial Officer	Chief Commercial Officer	▼ SELL	1,800	2.00	$4K	−2.3%	Form 4 ↗
Sep 11	Sep 10	Tiffany Eul Davis InglisChief Medical Officer	Chief Medical Officer	▼ SELL	486	2.00	$972	−0.5%	Form 4 ↗
Sep 9	Sep 8	Zhenya LindgardtCEO	CEO	▼ SELL	20,139	2.00	$40K	−2.3%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Tiffany Eul Davis Inglis	Chief Medical Officer	$0	2	$17K	Oct 13, 2026
Zhenya Lindgardt	CEO	$0	2	$54K	Sep 11, 2026
Benjamin Jackson	General Counsel	$0	1	$4K	Sep 11, 2026
Dyaarl Lee Anderson Jr	Chief Commercial Officer	$0	1	$4K	Sep 11, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →